The FDA requested additional clinical data from Unicycive Therapeutics.
4 reports, 3 independent
Updated 00:00
Still developing
- Reports
- 4
- Developments
- 3
- Repetition
- 25%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA requested additional clinical data from Unicycive Therapeutics.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.FDA issued a Complete Response Letter to Unicycive Therapeutics on its drug application.1 source
Lawsuit alleges misleading statements by Unicycive regarding FDA scrutiny.1 source
FDA requested more clinical data from Unicycive Therapeutics.1 source
Keep exploring
The entities involved
Related events
- FDA approval expands patient access to therapies for ACCORD.
- FDA provided guidance for HCW Biologics' IND application.
- Research advances have led to the approval of new therapies by the FDA.
- FDA data is being utilized by Idan Hecht's team, who are affiliated with Mayo Clinic.
- Arthur Caplan questioned the FDA regarding the status of clinical trials in 2006.